32207466|t|Distinct microscopic mechanisms for the accelerated aggregation of pathogenic Tau mutants revealed by kinetic analysis.
32207466|a|The self-assembly of Tau protein into amyloid structures is associated with Alzheimer's disease and other tauopathies. Dominant familial mutations in the Tau gene, such as P301L and P301S, increase the propensity of the Tau protein to aggregate abnormally into filaments. A quantitative description of the fibrillization process of Tau will facilitate the understanding of the cytotoxicity of Tau aggregates and their intercellular spreading. Here, we investigated the aggregation kinetics of Tau and disease-associated P301L and P301S mutants by combined thioflavin T assay and kinetic modeling, which revealed the rate constants of individual microscopic steps in the process of amyloid formation. Compared to WT Tau, P301L shows a larger primary nucleation rate while P301S has higher elongation and fragmentation rates and a more apparent fibril annealing process. Cross-seeding assays and FRET experiments indicate that the structures of the fibrillar nuclei of the three variants are distinct. These results provide detailed insights into how the amyloid aggregation mechanism of Tau protein is affected by the familial mutations P301L and P301S, and relates the physical properties of Tau mutants to their pathogenic mechanism.
32207466	78	81	Tau	Gene	4137
32207466	141	144	Tau	Gene	4137
32207466	158	165	amyloid	Disease	MESH:C000718787
32207466	196	215	Alzheimer's disease	Disease	MESH:D000544
32207466	226	237	tauopathies	Disease	MESH:D024801
32207466	274	277	Tau	Gene	4137
32207466	292	297	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
32207466	302	307	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
32207466	340	343	Tau	Gene	4137
32207466	452	455	Tau	Gene	4137
32207466	497	509	cytotoxicity	Disease	MESH:D064420
32207466	513	516	Tau	Gene	4137
32207466	613	616	Tau	Gene	4137
32207466	640	645	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
32207466	650	655	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
32207466	676	688	thioflavin T	Chemical	MESH:C009462
32207466	801	818	amyloid formation	Disease	MESH:D058426
32207466	835	838	Tau	Gene	4137
32207466	840	845	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
32207466	891	896	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
32207466	1173	1180	amyloid	Disease	MESH:C000718787
32207466	1206	1209	Tau	Gene	4137
32207466	1256	1261	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
32207466	1266	1271	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
32207466	1312	1315	Tau	Gene	4137
32207466	Association	MESH:C000718787	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
32207466	Association	MESH:C000718787	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
32207466	Positive_Correlation	MESH:D058426	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
32207466	Positive_Correlation	MESH:D058426	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
32207466	Association	MESH:C000718787	4137
32207466	Association	MESH:D000544	4137
32207466	Association	MESH:D064420	4137
32207466	Association	MESH:D058426	4137
32207466	Association	MESH:D024801	4137
32207466	Association	MESH:C000718787	4137
32207466	Association	MESH:D058426	4137

